Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
about
Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic RelevanceCancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesMolecular Connections between Cancer Cell Metabolism and the Tumor MicroenvironmentIn vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147Crucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4)Anticancer targets in the glycolytic metabolism of tumors: a comprehensive reviewMonocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survivalRole of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis.Expression of BAF57 in ovarian cancer cells and drug sensitivity.Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysisPrognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.Anticancer agents that counteract tumor glycolysis.Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targetsOverexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device.The Role of Monocarboxylate Transporters and Their Chaperone CD147 in Lactate Efflux Inhibition and the Anticancer Effects of Terminalia chebula in Neuroblastoma Cell Line N2-A.Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.Monocarboxylate transporters in the brain and in cancer.Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer.CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patientsMCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.Targeting the latest hallmark of cancer: another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype.Targeting lactate metabolism for cancer therapeutics.Tumor glycolysis as a target for cancer therapy: progress and prospects.Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy.Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis.Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance.Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.The Role of pH Regulation in Cancer Progression.Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies.Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma.Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic targetComparative analysis of gene expression profiles for several migrating cell types identifies cell migration regulators.Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment.High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma.Transpulmonary pyruvate kinetics.
P2860
Q26766711-47CEBBFE-2097-40D5-9311-8F90995ECCE4Q26823118-A4E46397-155B-4553-9462-51C54CAAAE09Q28081657-E5BB7420-69AB-47CE-9507-E524E20915EAQ28482047-A0048A9A-5E7A-4CFA-8BE5-774089203807Q28535008-4D057462-A8EA-4A16-B4A3-9302363A2C17Q34028478-543E004E-109F-4D7B-8D29-4600321E6AB3Q34194681-BCA668DB-C561-4F8A-9707-F4CCDDE69010Q35211510-F883856D-5DB9-4E4A-B405-037A5E3DCBD8Q35538429-1AC23DB0-F91D-4062-A185-16E9B487BFF1Q35884610-5421FDCB-BD86-4885-9CC8-BDD69F237812Q36224507-360E4826-328E-4033-9448-75FFBAD46518Q36452381-43E249B2-09CF-44B5-AE60-519778AC492DQ36544108-48A05E10-2640-493B-99C9-7ECAD658A8C3Q36780735-41DC91A7-8818-4E52-BE14-99FCE944E815Q36872785-E06112B1-D8A6-40BF-8446-866AE136FFB4Q37143080-C0E80DA2-6F0E-431F-9045-6F16155472C1Q37187094-1373FD08-F9BD-484C-A70B-DD99018224E4Q37304378-C2D1935F-B42C-45B3-847B-E0730B87CE05Q37396842-5BB7D755-DEA3-4C32-9AB3-93B27D1F3836Q37534686-70F0E380-CC3D-4679-8A9C-E853ED4728DCQ37536613-87078A8C-EB9F-4FAC-86E0-D31DEB9180A4Q38058130-01FF1B4C-6D62-483C-98DF-CFFCF2A2E446Q38133722-87A4E8C8-B802-4F51-AA32-5045615359BAQ38168262-1B0CCED4-2E9D-4E55-88CC-CED496BEE017Q38181145-6A7F4619-845A-413A-8ABB-332E71036E7FQ38572516-D3011288-E689-4D0D-853A-2D3D812065A3Q38655417-89DE31C6-28CC-4466-8882-280F78DF9032Q38755261-0338AC00-48B1-42CC-A0F2-D72B3D9F9B91Q38828050-BA24CB36-E885-48C9-9A5C-B4AC042F2D08Q38936259-A8BB2BF0-8705-4936-BFC5-4B9F88EF8C07Q39061667-DBE4E20D-F010-4009-854C-A2D074DD7CC0Q39078549-9D50C0B8-1270-4D51-A352-605CD821723DQ39205930-1D4487F5-B24D-4401-BE04-3BF8D2880F0FQ39233873-30391888-5D67-4FD8-9399-537FE0EFA9DAQ39236993-ACE09FB7-C00B-474C-9EDA-3218C70EC6CBQ39390952-2056E43E-D1DA-4C82-9905-245D45BAB5A9Q42776330-24CB7F20-6116-4FAD-A453-A8A6994682B5Q43468842-DC2D2300-D64D-4657-B591-ADBA2AC27769Q45750314-230C89A7-FBFF-4F5D-B60D-DC0F7F5650F0Q46224366-734707CF-C1B4-4102-8238-A59CA2090A79
P2860
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Monocarboxylate transporters 1 ...... ty of human lung cancer cells.
@en
Monocarboxylate transporters 1 ...... ty of human lung cancer cells.
@nl
type
label
Monocarboxylate transporters 1 ...... ty of human lung cancer cells.
@en
Monocarboxylate transporters 1 ...... ty of human lung cancer cells.
@nl
prefLabel
Monocarboxylate transporters 1 ...... ty of human lung cancer cells.
@en
Monocarboxylate transporters 1 ...... ty of human lung cancer cells.
@nl
P2093
P2860
P1433
P1476
Monocarboxylate transporters 1 ...... ty of human lung cancer cells.
@en
P2093
Hidetaka Uramoto
Hiroto Izumi
Ke-Yong Wang
Kimitoshi Kohno
Mayu Takahashi
Shigeru Nishizawa
Tsunehiro Oyama
Yasuyuki Sasaguri
Yoshifumi Nakayama
P2860
P304
P356
10.1111/J.1349-7006.2011.01908.X
P577
2011-03-07T00:00:00Z